Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

AIDS Vaccines

Known as: vaccine AIDS, AIDS Vaccines [Chemical/Ingredient], aid vaccines 
Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent or treat AIDS. Some vaccines… Expand
National Institutes of Health

Related topics

Related topics

26 relations

Narrower (17)

AIDSVAXAIDSVAX B-EDNA-rAd5 vaccineDermaVir
Expand
HIV VaccineIn BloodProcess of secretionagonists
Expand

Broader (1)

Viral Vaccines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery
If immunized with an antigen of interest, transgenic mice with large portions of unrearranged human immunoglobulin loci can… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Immunology and the elusive AIDS vaccine
Developing a human immunodeficiency virus (HIV) vaccine is critical to end the global acquired immunodeficiency syndrome (AIDS… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
2005
Review
2005
HIV vaccine design: insights from live attenuated SIV vaccines
The International AIDS Vaccine Initiative has established a consortium to elucidate mechanisms of protection conferred by live… Expand
  • figure 1
  • table 1
Is this relevant?
Review
2004
Review
2004
Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors.
An increasing body of evidence suggests that a vaccine that elicits anti-HIV-1 cellular immunity could provide the basis for an… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Cytotoxic T Lymphocyte–based Control of Simian Immunodeficiency Virus Replication in a Preclinical AIDS Vaccine Trial
Recently, encouraging AIDS vaccine trials in macaques have implicated cytotoxic T lymphocytes (CTLs) in the control of the simian… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2002
Review
2002
Diversity Considerations in HIV-1 Vaccine Selection
Globally, human immunodeficiency virus–type 1 (HIV-1) is extraordinarily variable, and this diversity poses a major obstacle to… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes
Potent virus-specific cytotoxic T lymphocyte (CTL) responses elicited by candidate AIDS vaccines have recently been shown to… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2001
Highly Cited
2001
An Effective AIDS Vaccine Based on Live Attenuated Vesicular Stomatitis Virus Recombinants
We developed an AIDS vaccine based on attenuated VSV vectors expressing env and gag genes and tested it in rhesus monkeys… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine…
A safety and immunogenicity trial was conducted in vaccinia-immune and vaccinia-naive human immunodeficiency virus (HIV… Expand
Is this relevant?
Highly Cited
1990
Highly Cited
1990
Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160
THE development of a vaccine to provide protective immunity to human immunodeficiency virus type 1 (HIV-1), the virus causing… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE